Your email has been successfully added to our mailing list.

×
0.00763392857142862 -8.92857142857044E-05 0.0140624999999999 0.0223214285714285 0.0267857142857143 0.0669196428571427 0.0540178571428571 0.0569196428571428
Stock impact report

Akers Biosciences up 25% on in-license of coronavirus vaccine candidate [Seeking Alpha]

AKERS BIOSCIENCES INC COMMON S (AKER) 
US:NASDAQ Investor Relations: akersbio.com/investor-center
Company Research Source: Seeking Alpha
Healthcare | On the Move Akers Biosciences up 25% on in-license of coronavirus vaccine candidate Mar. 24, 2020 10:39 AM ET Akers Biosciences, Inc. (AKER) Douglas W. House Thinly traded nano cap Akers Biosciences ( +24.6% license deal Under the terms of the agreement, Akers will acquire Cystron Biotech LLC (the rights holder?) for $1M upfront plus 622,756 shares of common stock (or equivalents) and a royalty on net sales. It will also make additional cash and stock payments to the sellers of Cystron Biotech upon the achievement of certain milestones, along with a change of control. It will also make cash payments to Premas if certain milestones are achieved. See all stocks on the move » Now read: Genprex bolsters Board of Directors; shares up 13% premarket » Show less Read more
Impact Snapshot
Event Time:
AKER
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AKER alerts
Opt-in for
AKER alerts

from News Quantified
Opt-in for
AKER alerts

from News Quantified